| Biomarker ID | 1054 |
| PMID | 23356551 |
| Year | 2013 |
| Biomarker | Prostate Specific Antigen (PSA) |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | OR :1.04 (95% CI:1.03-1.05) |
| Effect on Pathways | NA |
| Experiment | PC (stage II, III, IV) vs. other (PC stage I, PIN, BPH, prostatitis) |
| Type of Biomarker | Diagnostic |
| Cohort | 616 US Veterans with Prostate Cancer, along with 732 patients categorised as non cancerous (342 Prostatis, 282 BPH, 138 PIN) were chosen for the study. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p < 0.001 |
| Method Used | NA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |